Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2021-03-09

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s11010-021-04120-6PMID 33687588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting tau hyperphosphorylation via kinase inhibition- Strategy to address Alzheimers' disease.

  2020cited by this paper
• Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy

  2020cited by this paper
• MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy

  2020cited by this paper
• Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases.

  2020cited by this paper
• Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System

  2020cited by this paper
• Dance movement therapy in rehabilitation of Parkinson's disease - A feasibility study.

  2020cited by this paper
• Donepezil in the treatment of Alzheimer's disease

  2020cited by this paper
• Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer’s disease

  2020cited by this paper
• Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model

  2020cited by this paper
• Music Therapy and Dance as Gait Rehabilitation in Patients With Parkinson Disease: A Review of Evidence

  2019cited by this paper
• Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease

  2019cited by this paper
• Midlife Hypertension and Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2019cited by this paper
• Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones

  2019cited by this paper
• Dementia with Lewy bodies: an update and outlook

  2019cited by this paper
• Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

  2019cited by this paper
• Association between Hypertension and the Risk of Parkinson’s Disease: A Meta-Analysis of Analytical Studies

  2019cited by this paper
• Inflammasomes in neuroinflammatory and neurodegenerative diseases

  2019cited by this paper
• NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease

  2018cited by this paper
• G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain

  2018cited by this paper
• Genetics of Parkinson's disease

  2018cited by this paper
• Social Engagement and Its Change are Associated with Dementia Risk among Chinese Older Adults: A Longitudinal Study

  2018cited by this paper
• 2018 Alzheimer's disease facts and figures

  2018cited by this paper
• Mechanism of NMDA receptor channel block by MK-801 and memantine

  2018cited by this paper
• Insulin Peptides as Mediators of the Impact of Life Style in Alzheimer’s disease

  2018cited by this paper
• Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy

  2018cited by this paper
• Association between periodontitis and risk of Alzheimer′s disease, mild cognitive impairment and subjective cognitive decline: A case–control study

  2018cited by this paper
• The burden of Parkinson's disease: a worldwide perspective.

  2018cited by this paper
• Psychosocial interventions for Alzheimer’s disease cognitive symptoms: a Bayesian network meta-analysis

  2018cited by this paper
• Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: A systematic review

  2018cited by this paper
• Exercise Training for Persons with Alzheimer's Disease and Caregivers: A Review of Dyadic Exercise Interventions

  2017cited by this paper
• In situ click chemistry generation of cyclooxygenase-2 inhibitors

  2017cited by this paper
• Presenilin-1 mutations and Alzheimer’s disease

  2017cited by this paper
• TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease

  2017cited by this paper
• Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease.

  2017cited by this paper
• Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.

  2017cited by this paper
• Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer’s disease

  2017cited by this paper
• Music therapy is a potential intervention for cognition of Alzheimer’s Disease: a mini-review

  2017cited by this paper
• Classics in Chemical Neuroscience: Memantine.

  2017cited by this paper
• Protein aggregation, misfolding and consequential human neurodegenerative diseases

  2017cited by this paper
• PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress

  2017cited by this paper
• Intake of dairy foods and risk of Parkinson disease

  2017cited by this paper
• Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays

  2017cited by this paper
• Personality Change in the Preclinical Phase of Alzheimer Disease

  2017cited by this paper
• G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons

  2016cited by this paper
• Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.

  2016cited by this paper
• Trends in the Incidence of Parkinson Disease in the General Population: The Rotterdam Study.

  2016cited by this paper
• Age, APOE and sex: Triad of risk of Alzheimer's disease.

  2016cited by this paper
• Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.

  2016cited by this paper
• Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment

  2016cited by this paper
• Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease

  2016cited by this paper
• Protein aggregation and neurodegenerative diseases: From theory to therapy.

  2016cited by this paper
• Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration

  2016cited by this paper
• Epidemiology of Parkinson Disease.

  2016cited by this paper
• Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors

  2015cited by this paper
• A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson’s disease

  2015cited by this paper
• Cerebrovascular Disease, Amyloid Plaques, and Dementia

  2015cited by this paper
• Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition

  2015cited by this paper
• Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

  2015cited by this paper
• Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

  2015cited by this paper
• Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer’s Disease: Insights from Meta-Analyses

  2015cited by this paper
• Personality traits and the risk for Parkinson disease: a prospective study

  2015cited by this paper
• Interventions to Slow Aging in Humans: Are We Ready?

  2015cited by this paper
• Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study

  2015cited by this paper
• Dance therapy for individuals with Parkinson's disease: improving quality of life

  2014cited by this paper
• Personality and risk of Alzheimer's disease: New data and meta‐analysis

  2014cited by this paper
• The neurology of folic acid deficiency.

  2014cited by this paper
• Cognitive impairment and dementia in Parkinson's disease: Practical issues and management

  2014cited by this paper
• Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Targeting the β secretase BACE1 for Alzheimer's disease therapy.

  2014cited by this paper
• Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

  2014cited by this paper
• The neurology of folic acid deficiency.

  2014cited by this paper
• Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences

  2014cited by this paper
• Alzheimer's disease genetics: from the bench to the clinic.

  2014cited by this paper
• Exposure to pesticides or solvents and risk of Parkinson disease

  2013cited by this paper
• Advances in the genetics of Parkinson disease

  2013cited by this paper
• Microtubule Affinity-Regulating Kinase 4: Structure, Function, and Regulation

  2013cited by this paper
• Twenty years of Alzheimer’s disease‐causing mutations

  2012cited by this paper
• Genetics of Parkinson's disease.

  2012cited by this paper
• Disengagement coping partially mediates the relationship between caregiver burden and anxiety and depression in caregivers of people with Alzheimer's disease. Results from the MÁLAGA-AD study.

  2012cited by this paper
• Cognitive stimulation to improve cognitive functioning in people with dementia.

  2012cited by this paper
• Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

  2012cited by this paper
• Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012cited by this paper
• Diabetes and Risk of Parkinson’s Disease

  2011cited by this paper
• Amyloid precursor protein processing and Alzheimer's disease.

  2011cited by this paper
• Brain microbleeds: more evidence, but still a clinical dilemma.

  2011cited by this paper
• Diet and Alzheimer’s disease risk factors or prevention: the current evidence

  2011cited by this paper
• Depression in dementia: epidemiology, mechanisms, and treatment

  2011cited by this paper
• The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study

  2011cited by this paper
• Upregulation of the α‐secretase ADAM10 – risk or reason for hope?

  2010cited by this paper
• Caffeine Exposure and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis of Observational Studiess

  2010cited by this paper
• Cholesterol and statins in Alzheimer's disease: current controversies.

  2010cited by this paper
• [Depression in Parkinson's disease].

  2009cited by this paper
• Common features between diabetes mellitus and Alzheimer’s disease

  2009cited by this paper
• Education, Occupation, and Dementia: The Bavarian School Sisters Study

  2009cited by this paper
• EDUCATION AND DEMENTIA: WHAT LIES BEHIND THE ASSOCIATION?

  2008cited by this paper
• Cognitive stimulation for the treatment of Alzheimer’s disease

  2008cited by this paper
• Pathogenic mutations in Parkinson disease

  2007cited by this paper
• Education and dementia

  2007cited by this paper
• Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease

  2007cited by this paper

• Pharmacokinetics, Tissue Distribution, and Metabolic Profile of Cyanidin 3‐O‐β‐Galactoside Purified From Black Chokeberry

  2025cites this paper
• Neuroprotective activity of mung bean (Vigna radiata) coat extract via AMPK-dependent autophagy in Alzheimer's and Parkinson's models.

  2025cites this paper
• Therapeutic approaches in proteinopathies.

  2024cites this paper
• Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics.

  2024cites this paper
• Socioeconomic Disparities in Neurodegenerative Disease Mortality: A Population-Based Study among Belgian Men and Women Aged 65 or Older

  2024cites this paper
• Physical Activity Regulates and Mediates the Signaling Pathway and Pathophysiological Mechanisms of the Neuroinflammation and Neurodegenerative

  2024cites this paper
• The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions

  2023cites this paper
• Nano-mediated Strategies for Metal Ion–Induced Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases

  2022cites this paper
• Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?

  2022cites this paper
• Investigation of Whole and Glandular Saliva as a Biomarker for Alzheimer’s Disease Diagnosis

  2022cites this paper
• Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy

  2022cites this paper
• Age-related mitochondrial dysfunction in Parkinson's disease: new insights into the disease pathology.

  2022cites this paper
• Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases

  2022cites this paper
• Small GTPases of the Rab and Arf Families: Key Regulators of Intracellular Trafficking in Neurodegeneration

  2021cites this paper
• Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis.

  2021cites this paper
• Structural genomics approach to investigate deleterious impact of nsSNPs in conserved telomere maintenance component 1

  2021cites this paper